Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controls

Histochem Cell Biol. 2023 Jun;159(6):527-535. doi: 10.1007/s00418-022-02163-4. Epub 2022 Dec 20.

Abstract

The non-classical human leucocyte antigen (HLA) class I molecule HLA-G is widely known to play a major role in feto-maternal tolerance. We tested the hypothesis that HLA-G expression is altered in placentas of women with gestational diabetes mellitus (GDM) in a specific pattern that depends on fetal sex. HLA-G expression was analysed in a total of 80 placentas (40 placentas from women with GDM and 40 healthy controls) by immunohistochemistry using the semi-quantitative immunoreactive score (IRS). Double immunofluorescence staining identified the cells expressing HLA-G in the decidua and allowed evaluation of the expression pattern. We found a significant (p < 0.001) reduction of HLA-G expression in extravillous cytotrophoblasts (EVTs) in the placentas of women with GDM as compared to the healthy controls and were able to demonstrate that this downregulation was not due to a loss of cell number, but to a loss of expression intensity. A special change in the cell pattern of EVTs was observed, with these cells showing an obvious decrease in HLA-G expression on their cell surface. No significant differences according to fetal sex were found. These data show a possible association between decreased HLA-G expression and presence of GDM and provide new insights into altered placental function in women with GDM.

Keywords: Diabetes; HLA-G; Human; Pregnancy; Sex; Trophoblast.

MeSH terms

  • Diabetes, Gestational* / metabolism
  • Female
  • HLA-G Antigens / metabolism
  • Humans
  • Immunohistochemistry
  • Placenta* / metabolism
  • Pregnancy
  • Trophoblasts / metabolism

Substances

  • HLA-G Antigens